Bernstein: Positive VESALIUS-CV Data Is 'Great News for Amgen (AMGN)'
Tweet Send to a Friend
Bernstein SocGen Group analyst Courtney Breen reiterated an Outperform rating and $335.00 price target on Amgen (NASDAQ: AMGN).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
